Skip to main content
62°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
193.40
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Aug 15, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about AbbVie
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
58
59
Next >
3 Top Dividend Growth Stocks to Buy in 2024
January 02, 2024
Income investors should love these great stocks.
Via
The Motley Fool
The 3 Hottest Dividend Stocks to Watch in 2024
January 01, 2024
With 2023 in the books and the entirety of 2024 ahead of us, here are compelling dividend stocks to watch for astute investors.
Via
InvestorPlace
3 Top ETFs I'm Planning to Buy Hand Over Fist in 2024, Despite All the Cheap Stocks on My Radar
January 01, 2024
I'm adding some ETFs to my retirement portfolio in 2024; here are the three I'm starting with.
Via
The Motley Fool
Topics
ETFs
Retirement
Exposures
Pension
Got $1,500? You Can Confidently Add These 3 Stocks to Your Portfolio
December 31, 2023
Getting going on investing is a terrific way to start 2024.
Via
The Motley Fool
4 Incredible Dividend Stocks Yielding 4%-Plus to Buy in 2024
December 31, 2023
These companies pay attractive dividends that should continue rising.
Via
The Motley Fool
Peering Into AbbVie's Recent Short Interest
December 29, 2023
Via
Benzinga
Market Whales and Their Recent Bets on ABBV Options
December 22, 2023
Via
Benzinga
$100 Invested In This Stock 10 Years Ago Would Be Worth $300 Today
December 21, 2023
Via
Benzinga
8 Analysts Have This to Say About AbbVie
December 18, 2023
Via
Benzinga
Upward Trajectory For Biotech/Pharma M&A: Sector Trends Towards Pre-Pandemic Levels, Forecasts Positive For 2024
December 29, 2023
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2023.
Via
Benzinga
Common Investing Mistake: Income Obsession (& More)
December 28, 2023
A common investing mistake is income obsession. Others are holding too many stocks and focusing on valuation to know if the price of a stock is right. Sounds familiar? Any of these mistakes hurts your...
Via
Talk Markets
Small Caps Are On A Tear Including Speculative Biotechs
December 26, 2023
So far 2023 is going well with our game plan -an end-of-year seasonal rally coupled with a run in speculative biotechs driven by innovation.
Via
Talk Markets
AbbVie's Recent ImmunoGen Acquisition Looks Brilliant: Here's Why
December 26, 2023
The acquisition fills an immediate need with some extras to boot.
Via
The Motley Fool
Better Income Stock: AT&T or AbbVie?
December 17, 2023
These two blue chips are highly prized for their top-shelf dividend programs.
Via
The Motley Fool
Decoding AbbVie's Options Activity: What's the Big Picture?
December 14, 2023
Via
Benzinga
$100 Invested In AbbVie 10 Years Ago Would Be Worth This Much Today
December 13, 2023
Via
Benzinga
29 Undervalued Dividend Aristocrats: December 2023
December 25, 2023
The S&P 500 Dividend Aristocrats Index contains 67 dividend growth stocks called the Dividend Aristocrats.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Better Growth Stock: AbbVie vs. Abbott Laboratories
December 21, 2023
Do Humira's declining sales give Abbott Laboratories the edge as the better growth stock?
Via
The Motley Fool
7 Blue-Chip Dividend Stocks to Buy Before Dec. 31
December 19, 2023
Always a strong investment, blue-chip dividend stocks continue to make sense as 2023 draws closer to an end and 2024 nears.
Via
InvestorPlace
7 ‘Bulletproof’ Stocks to Buy Ahead of a Wild New Year
December 19, 2023
If you don’t quite trust the hyper-bullish narrative, these ideas can help boost confidence.
Via
InvestorPlace
Stock(ing) Stuffers That Could Be Lovin The High 2024
December 18, 2023
Via
Talk Markets
Healthcare Sector Stocks: Consistent Above-Average Growth And Income
December 18, 2023
The healthcare sector is full of many really good companies with consistent, long term, above-average growth rates and many that have good, consistent, long-term dividend records.
Via
Talk Markets
3 of the Most Attractive Dividend Stocks in the Pharma Space
December 17, 2023
Discover the resilience and growth potential of pharma dividend stocks, offering stability and consistency in the healthcare sphere.
Via
InvestorPlace
Dividend Income Update For November 2023
December 16, 2023
It’s dividend income update time. This is one of my favorite times of the month, as I get to review the previous month of passive income received from my dividend income portfolio.
Via
Talk Markets
3 Fantastic Stocks That Could Enjoy a Santa Claus Rally
December 16, 2023
These stocks could bring investors more than just a lump of coal for Christmas.
Via
The Motley Fool
Exposures
Coal
10 Health Care Stocks Whale Activity In Today's Session
December 14, 2023
Via
Benzinga
The 7 Most Undervalued Growth Stocks to Buy in December
December 13, 2023
Buy these distressed names now and ride their share prices higher over the coming year as they stage a comeback.
Via
InvestorPlace
Economic Safety Nets: 7 Defensive Stocks Providing Portfolio Stability
December 13, 2023
Although some signs of economic progress is seen, other signs suggest that investors should consider defensive stock picks.
Via
InvestorPlace
Botox And Similar Injections Have Associated Risks: Consumer Group Pushes for Stronger Warnings
December 12, 2023
Consumer advocacy group Public Citizen has filed a petition with the FDA, urging the agency to demand stronger warnings regarding the risk of a potentially fatal muscle-paralyzing disease linked to...
Via
Benzinga
Exposures
Product Safety
AbbVie Just Followed Pfizer's Big Move. Here's What It Means For Investors
December 12, 2023
It's making a major acquisition to beef up a key area of its pipeline.
Via
The Motley Fool
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
58
59
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.